Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Receives Average Rating of “Reduce” from Brokerages

Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBAGet Free Report) have been given an average recommendation of “Reduce” by the thirteen ratings firms that are covering the stock, Marketbeat reports. Four investment analysts have rated the stock with a sell recommendation, eight have given a hold recommendation and one has issued a buy recommendation on the company. The average 1-year price objective among brokers that have issued ratings on the stock in the last year is $24.92.

Several equities research analysts have issued reports on the company. Barclays initiated coverage on Walgreens Boots Alliance in a research note on Wednesday, January 3rd. They set an “underweight” rating and a $21.00 price target for the company. Bank of America cut their target price on Walgreens Boots Alliance from $23.00 to $22.00 and set an “underperform” rating for the company in a research note on Tuesday, March 26th. SVB Leerink reduced their price target on shares of Walgreens Boots Alliance from $23.00 to $22.00 and set a “market perform” rating on the stock in a research report on Monday, March 18th. HSBC restated a “reduce” rating and issued a $20.00 price objective (down from $27.00) on shares of Walgreens Boots Alliance in a report on Tuesday, February 20th. Finally, Raymond James reaffirmed a “market perform” rating on shares of Walgreens Boots Alliance in a report on Tuesday, March 26th.

View Our Latest Report on Walgreens Boots Alliance

Walgreens Boots Alliance Trading Down 4.2 %

Shares of WBA stock opened at $18.72 on Wednesday. Walgreens Boots Alliance has a 52-week low of $18.67 and a 52-week high of $36.58. The business’s fifty day moving average is $21.65 and its 200 day moving average is $22.26. The company has a debt-to-equity ratio of 0.50, a quick ratio of 0.32 and a current ratio of 0.66. The company has a market capitalization of $16.14 billion, a PE ratio of -2.67, a price-to-earnings-growth ratio of 1.34 and a beta of 0.73.

Walgreens Boots Alliance (NASDAQ:WBAGet Free Report) last issued its quarterly earnings results on Thursday, March 28th. The pharmacy operator reported $1.20 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.82 by $0.38. The firm had revenue of $37.05 billion during the quarter, compared to the consensus estimate of $35.86 billion. Walgreens Boots Alliance had a positive return on equity of 12.11% and a negative net margin of 4.18%. The company’s revenue for the quarter was up 6.3% on a year-over-year basis. During the same quarter last year, the company posted $1.16 EPS. On average, equities research analysts anticipate that Walgreens Boots Alliance will post 3.25 EPS for the current fiscal year.

Insider Activity

In related news, CEO Timothy C. Wentworth acquired 10,000 shares of Walgreens Boots Alliance stock in a transaction on Friday, January 5th. The shares were acquired at an average cost of $24.22 per share, with a total value of $242,200.00. Following the transaction, the chief executive officer now owns 585,122 shares in the company, valued at $14,171,654.84. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. In related news, CEO Timothy C. Wentworth acquired 10,000 shares of the stock in a transaction on Friday, January 5th. The stock was acquired at an average cost of $24.22 per share, for a total transaction of $242,200.00. Following the completion of the acquisition, the chief executive officer now directly owns 585,122 shares of the company’s stock, valued at approximately $14,171,654.84. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, CFO Manmohan Mahajan bought 6,000 shares of Walgreens Boots Alliance stock in a transaction on Tuesday, April 2nd. The shares were purchased at an average price of $19.38 per share, for a total transaction of $116,280.00. Following the acquisition, the chief financial officer now directly owns 166,969 shares in the company, valued at approximately $3,235,859.22. The disclosure for this purchase can be found here. Over the last three months, insiders have acquired 20,456 shares of company stock valued at $458,473. Company insiders own 17.40% of the company’s stock.

Institutional Trading of Walgreens Boots Alliance

Hedge funds have recently modified their holdings of the business. HighPoint Advisor Group LLC bought a new position in shares of Walgreens Boots Alliance during the fourth quarter valued at approximately $2,094,000. Quadrature Capital Ltd purchased a new position in Walgreens Boots Alliance during the fourth quarter valued at $837,000. Hennessy Advisors Inc. boosted its holdings in Walgreens Boots Alliance by 30.8% in the fourth quarter. Hennessy Advisors Inc. now owns 162,500 shares of the pharmacy operator’s stock worth $4,243,000 after acquiring an additional 38,250 shares in the last quarter. PVG Asset Management Corp purchased a new stake in shares of Walgreens Boots Alliance in the fourth quarter worth $372,000. Finally, Wahed Invest LLC increased its holdings in shares of Walgreens Boots Alliance by 9.4% during the fourth quarter. Wahed Invest LLC now owns 12,229 shares of the pharmacy operator’s stock valued at $319,000 after acquiring an additional 1,049 shares in the last quarter. Institutional investors own 58.59% of the company’s stock.

Walgreens Boots Alliance Company Profile

(Get Free Report

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.

See Also

Analyst Recommendations for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.